Sign In
Buy ODD
$15.31
+0.0800 (+0.525%)
At Close: Aug 04, 2026
Can Oddity Tech (ODD) Keep the Earnings Surprise Streak Alive?
01:11pm, Thursday, 06'th Feb 2025
Oddity Tech (ODD) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
ODDITY Announces New $200 Million Credit Facility
04:05pm, Friday, 31'st Jan 2025
NEW YORK, Jan. 31, 2025 (GLOBE NEWSWIRE) -- On January 31, 2025, ODDITY Tech Ltd. (NASDAQ: ODD, the “Company”) entered into agreements with a syndicate of banks to secure credit facilities for a
ODDITY Rises 6.7% in 3 Months: How Should You Play the Stock?
09:36am, Monday, 06'th Jan 2025
ODD is disrupting the legacy beauty and wellness market with technologies like AI, machine learning, data science and computer vision.
Best Growth Stocks to Buy for January 6th
04:40am, Monday, 06'th Jan 2025
ODD, ROAD, and NCNO it to the Zacks Rank #1 (Strong Buy) growth stocks list on January 6, 2024.
4 Top-Ranked Liquid Stocks to Enhance Portfolio Returns in 2025
09:00am, Tuesday, 31'st Dec 2024
Investors can boost returns by adding these top-ranked liquid stocks, DXP Enterprises, Ubiquiti, Sezzle and Oddity Tech, to their portfolios.
IPO Stock Roundup: Astera, Reddit Hit New Highs; Atour, Oddity Trigger Sell Signals
02:24pm, Friday, 27'th Dec 2024
Top IPO stocks Astera and Reddit hit new highs this week. Birkenstock is near a buy point.
FDA Grants Revascor® (Rexlemestrocel-L) Regenerative Medicine Advanced Therapy (RMAT) Designation in Children with Congenital Heart Disease
06:32pm, Wednesday, 04'th Dec 2024
Earlier this year FDA granted REVASCOR both Rare Pediatric Disease Designation (RPDD) and Orphan-Drug Designation (ODD) for congenital heart disease Earlier this year FDA granted REVASCOR both Rare Pe
Oddity Tech: Executing Well (Rating Upgrade)
03:30pm, Wednesday, 04'th Dec 2024
Oddity Tech's data-driven, AI-powered DTC model looks set to facilitate market share gains through FY28. ODD's forward EV/EBITDA valuation of 16.2x is pricier than the industry average, but we feel it
This AI Stock Picks The Perfect Lipstick
01:32pm, Friday, 29'th Nov 2024
AI stock Oddity hit a new buy point this week. The Israeli retailer uses AI to deliver a precise product match to customers.
Enrich Your Portfolio With These 4 Top-Ranked Liquid Stocks
08:25am, Monday, 25'th Nov 2024
Investors can add these top-ranked liquid stocks, American Superconductor Corporation, Angi, Sezzle and Oddity Tech, to their portfolios to boost returns.
Oddity Tech (ODD) Recently Broke Out Above the 20-Day Moving Average
10:35am, Friday, 22'nd Nov 2024
From a technical perspective, Oddity Tech (ODD) is looking like an interesting pick, as it just reached a key level of support. ODD recently overtook the 20-day moving average, and this suggests a sho
Can Oddity Tech (ODD) Climb 28.74% to Reach the Level Wall Street Analysts Expect?
11:01am, Wednesday, 20'th Nov 2024
The mean of analysts' price targets for Oddity Tech (ODD) points to a 28.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analy
What Makes Oddity Tech (ODD) a New Strong Buy Stock
01:05pm, Friday, 15'th Nov 2024
Oddity Tech (ODD) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
L Catterton Agrees to Sell $100 Million of Shares Back to ODDITY
05:19pm, Wednesday, 13'th Nov 2024
NEW YORK, Nov. 13, 2024 (GLOBE NEWSWIRE) -- ODDITY Tech Ltd. (NASDAQ: ODD) today announced that it has entered into a transaction with a fund managed by L Catterton (“L Catterton”) to repurchase
Oddity Tech Ltd (ODD) Q3 2024 Earnings Call Transcript
10:34am, Saturday, 09'th Nov 2024
Oddity Tech Ltd (NASDAQ:ODD ) Q3 2024 Results Conference Call November 7, 2024 8:30 AM ET Company Participants Maria Lycouris - Investor Relations Oran Holtzman - Co-Founder and Chief Executive Office
